|
Volumn 16, Issue 14, 2002, Pages 1959-1961
|
Evolution of the gp41 env region in HIV-infected patients receiving T-20, a fusion inhibitor
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
ENFUVIRTIDE;
GLYCOPROTEIN GP 41;
VIRUS ENVELOPE PROTEIN;
AMINO ACID SUBSTITUTION;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
ANTIBIOTIC THERAPY;
ARTICLE;
CASE REPORT;
CONTROLLED STUDY;
DRUG INDUCED DISEASE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
NUCLEOTIDE SEQUENCE;
PRIORITY JOURNAL;
SEQUENCE ANALYSIS;
TREATMENT FAILURE;
VIRAL GENETICS;
VIRUS CELL INTERACTION;
VIRUS GENE;
VIRUS INHIBITION;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
AMINO ACID SUBSTITUTION;
ANTI-HIV AGENTS;
CD4-POSITIVE T-LYMPHOCYTES;
EVOLUTION, MOLECULAR;
HIV ENVELOPE PROTEIN GP41;
HIV-1;
HUMANS;
PEPTIDE FRAGMENTS;
RECEPTORS, CCR5;
SEQUENCE ANALYSIS, DNA;
VIREMIA;
|
EID: 0037183892
PISSN: 02699370
EISSN: None
Source Type: Journal
DOI: 10.1097/00002030-200209270-00014 Document Type: Article |
Times cited : (56)
|
References (7)
|